skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: State of the art address oncogenes and tumor-suppressing genes

Conference ·
OSTI ID:6698984

Cancer has a myriad of causes but, whatever the cause, the changes that result in neoplasia are usually genetic. Although not all DNA damage results in cancer, evidence implicates two broad classes of genes in carcinogenesis. The first class, oncogenes are genes that cause cancer. An oncogene results when there is increased and/or changed expression of the proto-oncogene. Oncogenes are dominant: when activated, they predominate over the activity of any normal alleles in the cell. Thus oncogenes act directly to cause cancer. The second class of genes associated with cancer are tumor-suppressing genes, which either code directly for, or control expression of a wide spectrum of tissue-specific differentiation antigens. Malignancy occurs in a specific cell type when expression of an appropriate tumor-suppressing gene is, homozygously, seriously distorted or completely lacking. Tumor suppressing genes also appear to regulate expression of a third, uncharacterized group of cancer-related genes that act in a recessive manner and are not expressed in the presence of the tumor-suppressing genes. We will first discuss oncogenes, then the tumor-suppressing genes. Experimental data will be used to illustrate key features of the carcinogenic process.

Research Organization:
Pacific Northwest Lab., Richland, WA (USA)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
AC06-76RL01830
OSTI ID:
6698984
Report Number(s):
PNL-SA-16891; CONF-9005256-1; ON: DE90015550
Resource Relation:
Conference: 7. annual veterinary medicine forum, San Diego, CA (USA), 25-28 May 1990
Country of Publication:
United States
Language:
English